A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics

  1. Irene Gallego Romero  Is a corresponding author
  2. Bryan J Pavlovic
  3. Irene Hernando-Herraez
  4. Xiang Zhou
  5. Michelle C Ward
  6. Nicholas E Banovich
  7. Courtney L Kagan
  8. Jonathan E Burnett
  9. Constance H Huang
  10. Amy Mitrano
  11. Claudia I Chavarria
  12. Inbar Friedrich Ben-Nun
  13. Yingchun Li
  14. Karen Sabatini
  15. Trevor R Leonardo
  16. Mana Parast
  17. Tomas Marques-Bonet
  18. Louise C Laurent
  19. Jeanne F Loring
  20. Yoav Gilad
  1. University of Chicago, United States
  2. Institució Catalana de Recerca i Estudis Avançats, Spain
  3. University of Michigan, United States
  4. Lonza Walkersville, Inc., United States
  5. University of California San Diego, United States
  6. The Scripps Research Institute, United States
  7. Sanford Consortium for Regenerative Medicine, United States

Abstract

Comparative genomics studies in primates are restricted due to our limited access to samples. In order to gain better insight into the genetic processes that underlie variation in complex phenotypes in primates, we must have access to faithful model systems for a wide range of cell types. To facilitate this, we generated a panel of 7 fully characterized chimpanzee induced pluripotent stem cell (iPSC) lines derived from healthy donors. To demonstrate the utility of comparative iPSC panels, we collected RNA-sequencing and DNA methylation data from the chimpanzee iPSCs and the corresponding fibroblast lines, as well as from 7 human iPSCs and their source lines, which encompass multiple populations and cell types. We observe much less within-species variation in iPSCs than in somatic cells, indicating the reprogramming process erases many inter-individual differences. The low within-species regulatory variation in iPSCs allowed us to identify many novel inter-species regulatory differences of small magnitude.

Article and author information

Author details

  1. Irene Gallego Romero

    Department of Human Genetics, University of Chicago, Chicago, United States
    For correspondence
    ireneg@uchicago.edu
    Competing interests
    The authors declare that no competing interests exist.
  2. Bryan J Pavlovic

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Irene Hernando-Herraez

    Institute of Evolutionary Biology, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  4. Xiang Zhou

    Department of Biostatistics, University of Michigan, Ann Arbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Michelle C Ward

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Nicholas E Banovich

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Courtney L Kagan

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Jonathan E Burnett

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Constance H Huang

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Amy Mitrano

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Claudia I Chavarria

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Inbar Friedrich Ben-Nun

    n/a, Lonza Walkersville, Inc., Walkersville, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Yingchun Li

    Department of Pathology, University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Karen Sabatini

    Center for Regenerative Medicine, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Trevor R Leonardo

    Center for Regenerative Medicine, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Mana Parast

    Department of Pathology, University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Tomas Marques-Bonet

    Institute of Evolutionary Biology, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  18. Louise C Laurent

    n/a, Sanford Consortium for Regenerative Medicine, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Jeanne F Loring

    Center for Regenerative Medicine, Department of Chemical Physiology, The Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  20. Yoav Gilad

    Department of Human Genetics, University of Chicago, Chicago, United States
    Competing interests
    The authors declare that no competing interests exist.

Reviewing Editor

  1. Duncan T Odom, Cancer Research UK Cambridge Institute, United Kingdom

Version history

  1. Received: February 19, 2015
  2. Accepted: June 22, 2015
  3. Accepted Manuscript published: June 23, 2015 (version 1)
  4. Version of Record published: July 15, 2015 (version 2)

Copyright

© 2015, Gallego Romero et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,952
    views
  • 810
    downloads
  • 108
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Irene Gallego Romero
  2. Bryan J Pavlovic
  3. Irene Hernando-Herraez
  4. Xiang Zhou
  5. Michelle C Ward
  6. Nicholas E Banovich
  7. Courtney L Kagan
  8. Jonathan E Burnett
  9. Constance H Huang
  10. Amy Mitrano
  11. Claudia I Chavarria
  12. Inbar Friedrich Ben-Nun
  13. Yingchun Li
  14. Karen Sabatini
  15. Trevor R Leonardo
  16. Mana Parast
  17. Tomas Marques-Bonet
  18. Louise C Laurent
  19. Jeanne F Loring
  20. Yoav Gilad
(2015)
A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics
eLife 4:e07103.
https://doi.org/10.7554/eLife.07103

Share this article

https://doi.org/10.7554/eLife.07103

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Rajdeep Banerjee, Thomas J Meyer ... David D Roberts
    Research Article

    Extramedullary erythropoiesis is not expected in healthy adult mice, but erythropoietic gene expression was elevated in lineage-depleted spleen cells from Cd47−/− mice. Expression of several genes associated with early stages of erythropoiesis was elevated in mice lacking CD47 or its signaling ligand thrombospondin-1, consistent with previous evidence that this signaling pathway inhibits expression of multipotent stem cell transcription factors in spleen. In contrast, cells expressing markers of committed erythroid progenitors were more abundant in Cd47−/− spleens but significantly depleted in Thbs1−/− spleens. Single-cell transcriptome and flow cytometry analyses indicated that loss of CD47 is associated with accumulation and increased proliferation in spleen of Ter119CD34+ progenitors and Ter119+CD34 committed erythroid progenitors with elevated mRNA expression of Kit, Ermap, and Tfrc. Induction of committed erythroid precursors is consistent with the known function of CD47 to limit the phagocytic removal of aged erythrocytes. Conversely, loss of thrombospondin-1 delays the turnover of aged red blood cells, which may account for the suppression of committed erythroid precursors in Thbs1−/− spleens relative to basal levels in wild-type mice. In addition to defining a role for CD47 to limit extramedullary erythropoiesis, these studies reveal a thrombospondin-1-dependent basal level of extramedullary erythropoiesis in adult mouse spleen.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine
    Mayank Verma, Yoko Asakura ... Atsushi Asakura
    Research Article Updated

    Endothelial and skeletal muscle lineages arise from common embryonic progenitors. Despite their shared developmental origin, adult endothelial cells (ECs) and muscle stem cells (MuSCs; satellite cells) have been thought to possess distinct gene signatures and signaling pathways. Here, we shift this paradigm by uncovering how adult MuSC behavior is affected by the expression of a subset of EC transcripts. We used several computational analyses including single-cell RNA-seq (scRNA-seq) to show that MuSCs express low levels of canonical EC markers in mice. We demonstrate that MuSC survival is regulated by one such prototypic endothelial signaling pathway (VEGFA-FLT1). Using pharmacological and genetic gain- and loss-of-function studies, we identify the FLT1-AKT1 axis as the key effector underlying VEGFA-mediated regulation of MuSC survival. All together, our data support that the VEGFA-FLT1-AKT1 pathway promotes MuSC survival during muscle regeneration, and highlights how the minor expression of select transcripts is sufficient for affecting cell behavior.